Cargando…
Beyond the Limits: Clinical Utility of Novel Cardiac Biomarkers
Preoperative assessment of cardiovascular risk is essential when it comes to extensive noncardiac surgery procedures. Therefore, accurate and timely diagnosis of myocyte damage is vital. In modern medical practice it is believed that the so-called “multimarker” approach is the most appropriate and m...
Autores principales: | Janković, Radmilo, Marković, Danica, Savić, Nenad, Dinić, Vesna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609335/ https://www.ncbi.nlm.nih.gov/pubmed/26504786 http://dx.doi.org/10.1155/2015/187384 |
Ejemplares similares
-
Peripartum Cardiomyopathy in Intensive Care Unit: An Update
por: Dinic, Vesna, et al.
Publicado: (2015) -
Response: “Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: An Update”
por: Dinic, Vesna, et al.
Publicado: (2016) -
Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study
por: Marković, Danica, et al.
Publicado: (2018) -
Enhanced Recovery in Thoracic Surgery: A Review
por: Dinic, Vesna D., et al.
Publicado: (2018) -
Enhanced Recovery after Vascular Surgery
por: Stojanovic, Milena D., et al.
Publicado: (2018)